Missouri AG files lawsuit against 19 pharmacy companies for alleged insulin pricing scheme
Missouri's Attorney General filed a lawsuit against 19 pharmacy companies alleging manipulation and fraud in insulin pricing.Summary
Missouri Attorney General Catherine Hanaway announced a lawsuit against 19 Pharmacy Benefit Manager (PBM) companies and drug manufacturers, alleging they manipulated the state’s healthcare markets and inflated the price of insulin. The lawsuit claims these companies prioritized profit over affordable healthcare, leading to significant price increases for uninsured Missouri residents with diabetes over the past fifteen years. Published manufacturing prices in Missouri were reportedly $300 to $400 for drugs sold for under $5 USD in other countries.
The Attorney General’s office argues that PBMs, acting as intermediaries between manufacturers, pharmacies, and insurers, failed to secure the lowest possible insulin prices for Missourians. Interim Deputy Attorney General Jeremiah Morgan stated that PBMs have been “gaming the system” for mutual benefit. The Missouri Pharmacy Business Council applauded the lawsuit, citing broader PBM abuses like opaque pricing and lack of transparency.
Simultaneously, Missouri lawmakers are considering legislation to regulate PBMs, aiming to address transparency and pricing disparities. Over 20 states introduced similar legislation in 2024, reflecting a growing national concern over PBM practices and drug pricing.
(Source：Newspressnow)